• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Rodman & Renshaw initiated coverage on Cormedix with a new price target

    8/26/24 7:31:35 AM ET
    $CRMD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CRMD alert in real time by email
    Rodman & Renshaw initiated coverage of Cormedix with a rating of Buy and set a new price target of $13.00
    Get the next $CRMD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CRMD

    DatePrice TargetRatingAnalyst
    3/7/2025$18.00Outperform
    Leerink Partners
    1/13/2025$15.00Buy
    D. Boral Capital
    8/26/2024$13.00Buy
    Rodman & Renshaw
    8/10/2023$6.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $CRMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Leerink Partners initiated coverage on Cormedix with a new price target

      Leerink Partners initiated coverage of Cormedix with a rating of Outperform and set a new price target of $18.00

      3/7/25 7:21:39 AM ET
      $CRMD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • D. Boral Capital initiated coverage on Cormedix with a new price target

      D. Boral Capital initiated coverage of Cormedix with a rating of Buy and set a new price target of $15.00

      1/13/25 8:29:07 AM ET
      $CRMD
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Rodman & Renshaw initiated coverage on Cormedix with a new price target

      Rodman & Renshaw initiated coverage of Cormedix with a rating of Buy and set a new price target of $13.00

      8/26/24 7:31:35 AM ET
      $CRMD
      Biotechnology: Pharmaceutical Preparations
      Health Care